Eisai
4523.T
#2184
Rank
โ‚น762.53 B
Marketcap
โ‚น2,703
Share price
0.11%
Change (1 day)
9.14%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: โ‚น47.24 Billion

According to Eisai's latest financial reports the company's current earnings are โ‚น5.06 Billion. In 2023 the company made an earning of โ‚น47.24 Billion, an increase over its 2022 earnings that were of -โ‚น2.06 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023โ‚น47.24 B-2404.04%
2022-โ‚น2.06 Billion-103.6%
2021โ‚น57.01 B-39.81%
2020โ‚น94.72 B7.44%
2019โ‚น88.16 B17.22%
2018โ‚น75.21 B86.16%
2017โ‚น40.40 B-23.52%
2016โ‚น52.82 B26.97%
2015โ‚น41.60 B22.3%
2014โ‚น34.02 B-46.07%
2013โ‚น63.08 B-21.85%
2012โ‚น80.71 B-20.59%
2011โ‚น101.64 B-8.91%
2010โ‚น111.59 B19.21%
2009โ‚น93.61 B